nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—ABCB1—Ezetimibe—atherosclerosis	0.106	0.152	CbGbCtD
Albendazole—ABCB1—Simvastatin—atherosclerosis	0.0989	0.141	CbGbCtD
Albendazole—ABCB1—Pravastatin—atherosclerosis	0.0968	0.138	CbGbCtD
Albendazole—ABCB1—Lovastatin—atherosclerosis	0.0968	0.138	CbGbCtD
Albendazole—CYP3A4—Ezetimibe—atherosclerosis	0.0638	0.0908	CbGbCtD
Albendazole—CYP3A4—Rosuvastatin—atherosclerosis	0.0638	0.0908	CbGbCtD
Albendazole—CYP3A4—Simvastatin—atherosclerosis	0.0593	0.0845	CbGbCtD
Albendazole—CYP3A4—Lovastatin—atherosclerosis	0.058	0.0827	CbGbCtD
Albendazole—CYP3A4—Pravastatin—atherosclerosis	0.058	0.0827	CbGbCtD
Albendazole—Renal failure acute—Rosuvastatin—atherosclerosis	0.00498	0.0269	CcSEcCtD
Albendazole—Renal failure acute—Pravastatin—atherosclerosis	0.00357	0.0193	CcSEcCtD
Albendazole—Liver function test abnormal—Ezetimibe—atherosclerosis	0.00353	0.019	CcSEcCtD
Albendazole—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00335	0.0181	CcSEcCtD
Albendazole—Hepatitis—Rosuvastatin—atherosclerosis	0.00318	0.0172	CcSEcCtD
Albendazole—Liver function test abnormal—Niacin—atherosclerosis	0.00309	0.0167	CcSEcCtD
Albendazole—Liver function test abnormal—Pravastatin—atherosclerosis	0.00304	0.0164	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.00298	0.0161	CcSEcCtD
Albendazole—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00278	0.015	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00278	0.015	CcSEcCtD
Albendazole—Hepatitis—Lovastatin—atherosclerosis	0.00269	0.0145	CcSEcCtD
Albendazole—Hepatitis—Ezetimibe—atherosclerosis	0.00264	0.0143	CcSEcCtD
Albendazole—Erythema multiforme—Lovastatin—atherosclerosis	0.00255	0.0138	CcSEcCtD
Albendazole—Hepatitis—Simvastatin—atherosclerosis	0.00252	0.0136	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00252	0.0136	CcSEcCtD
Albendazole—Erythema multiforme—Ezetimibe—atherosclerosis	0.0025	0.0135	CcSEcCtD
Albendazole—Immune system disorder—Ezetimibe—atherosclerosis	0.00239	0.0129	CcSEcCtD
Albendazole—Erythema multiforme—Simvastatin—atherosclerosis	0.00238	0.0129	CcSEcCtD
Albendazole—Alopecia—Lovastatin—atherosclerosis	0.00238	0.0129	CcSEcCtD
Albendazole—Alopecia—Ezetimibe—atherosclerosis	0.00234	0.0126	CcSEcCtD
Albendazole—Hepatitis—Niacin—atherosclerosis	0.00231	0.0125	CcSEcCtD
Albendazole—Hepatitis—Pravastatin—atherosclerosis	0.00228	0.0123	CcSEcCtD
Albendazole—Alopecia—Simvastatin—atherosclerosis	0.00223	0.012	CcSEcCtD
Albendazole—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00221	0.0119	CcSEcCtD
Albendazole—Erythema multiforme—Pravastatin—atherosclerosis	0.00215	0.0116	CcSEcCtD
Albendazole—Vertigo—Lovastatin—atherosclerosis	0.00211	0.0114	CcSEcCtD
Albendazole—Leukopenia—Lovastatin—atherosclerosis	0.0021	0.0113	CcSEcCtD
Albendazole—Alopecia—Niacin—atherosclerosis	0.00204	0.011	CcSEcCtD
Albendazole—Alopecia—Pravastatin—atherosclerosis	0.00201	0.0109	CcSEcCtD
Albendazole—Vertigo—Simvastatin—atherosclerosis	0.00197	0.0106	CcSEcCtD
Albendazole—Leukopenia—Simvastatin—atherosclerosis	0.00196	0.0106	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00194	0.0105	CcSEcCtD
Albendazole—Thrombocytopenia—Lovastatin—atherosclerosis	0.00187	0.0101	CcSEcCtD
Albendazole—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00185	0.00997	CcSEcCtD
Albendazole—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00184	0.00992	CcSEcCtD
Albendazole—Skin disorder—Ezetimibe—atherosclerosis	0.00182	0.00985	CcSEcCtD
Albendazole—Vertigo—Niacin—atherosclerosis	0.00181	0.00977	CcSEcCtD
Albendazole—Leukopenia—Niacin—atherosclerosis	0.0018	0.00973	CcSEcCtD
Albendazole—Urticaria—Rosuvastatin—atherosclerosis	0.00179	0.00969	CcSEcCtD
Albendazole—Abdominal pain—Rosuvastatin—atherosclerosis	0.00179	0.00964	CcSEcCtD
Albendazole—Vertigo—Pravastatin—atherosclerosis	0.00178	0.00962	CcSEcCtD
Albendazole—Leukopenia—Pravastatin—atherosclerosis	0.00178	0.00958	CcSEcCtD
Albendazole—Thrombocytopenia—Simvastatin—atherosclerosis	0.00175	0.00946	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.0017	0.0092	CcSEcCtD
Albendazole—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00166	0.00898	CcSEcCtD
Albendazole—Skin disorder—Niacin—atherosclerosis	0.0016	0.00862	CcSEcCtD
Albendazole—Thrombocytopenia—Pravastatin—atherosclerosis	0.00158	0.00856	CcSEcCtD
Albendazole—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00157	0.00845	CcSEcCtD
Albendazole—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00154	0.00829	CcSEcCtD
Albendazole—Urticaria—Lovastatin—atherosclerosis	0.00152	0.00821	CcSEcCtD
Albendazole—Abdominal pain—Lovastatin—atherosclerosis	0.00151	0.00817	CcSEcCtD
Albendazole—Body temperature increased—Lovastatin—atherosclerosis	0.00151	0.00817	CcSEcCtD
Albendazole—Dizziness—Rosuvastatin—atherosclerosis	0.00149	0.00806	CcSEcCtD
Albendazole—Urticaria—Ezetimibe—atherosclerosis	0.00149	0.00805	CcSEcCtD
Albendazole—Abdominal pain—Ezetimibe—atherosclerosis	0.00148	0.00801	CcSEcCtD
Albendazole—Body temperature increased—Ezetimibe—atherosclerosis	0.00148	0.00801	CcSEcCtD
Albendazole—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00146	0.0079	CcSEcCtD
Albendazole—Rash—Rosuvastatin—atherosclerosis	0.00142	0.00769	CcSEcCtD
Albendazole—Dermatitis—Rosuvastatin—atherosclerosis	0.00142	0.00768	CcSEcCtD
Albendazole—Urticaria—Simvastatin—atherosclerosis	0.00142	0.00768	CcSEcCtD
Albendazole—Abdominal pain—Simvastatin—atherosclerosis	0.00142	0.00764	CcSEcCtD
Albendazole—Body temperature increased—Simvastatin—atherosclerosis	0.00142	0.00764	CcSEcCtD
Albendazole—Headache—Rosuvastatin—atherosclerosis	0.00141	0.00764	CcSEcCtD
Albendazole—Hypersensitivity—Lovastatin—atherosclerosis	0.00141	0.00761	CcSEcCtD
Albendazole—Hypersensitivity—Ezetimibe—atherosclerosis	0.00138	0.00747	CcSEcCtD
Albendazole—Gastrointestinal pain—Niacin—atherosclerosis	0.00134	0.00726	CcSEcCtD
Albendazole—Nausea—Rosuvastatin—atherosclerosis	0.00134	0.00724	CcSEcCtD
Albendazole—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00132	0.00715	CcSEcCtD
Albendazole—Hypersensitivity—Simvastatin—atherosclerosis	0.00132	0.00712	CcSEcCtD
Albendazole—Urticaria—Niacin—atherosclerosis	0.00131	0.00705	CcSEcCtD
Albendazole—Abdominal pain—Niacin—atherosclerosis	0.0013	0.00702	CcSEcCtD
Albendazole—Body temperature increased—Niacin—atherosclerosis	0.0013	0.00702	CcSEcCtD
Albendazole—Urticaria—Pravastatin—atherosclerosis	0.00129	0.00694	CcSEcCtD
Albendazole—Abdominal pain—Pravastatin—atherosclerosis	0.00128	0.00691	CcSEcCtD
Albendazole—Body temperature increased—Pravastatin—atherosclerosis	0.00128	0.00691	CcSEcCtD
Albendazole—Dizziness—Lovastatin—atherosclerosis	0.00127	0.00683	CcSEcCtD
Albendazole—Dizziness—Ezetimibe—atherosclerosis	0.00124	0.0067	CcSEcCtD
Albendazole—Vomiting—Lovastatin—atherosclerosis	0.00122	0.00657	CcSEcCtD
Albendazole—Hypersensitivity—Niacin—atherosclerosis	0.00121	0.00654	CcSEcCtD
Albendazole—Rash—Lovastatin—atherosclerosis	0.00121	0.00652	CcSEcCtD
Albendazole—Dermatitis—Lovastatin—atherosclerosis	0.00121	0.00651	CcSEcCtD
Albendazole—Headache—Lovastatin—atherosclerosis	0.0012	0.00647	CcSEcCtD
Albendazole—Vomiting—Ezetimibe—atherosclerosis	0.00119	0.00644	CcSEcCtD
Albendazole—Hypersensitivity—Pravastatin—atherosclerosis	0.00119	0.00644	CcSEcCtD
Albendazole—Dizziness—Simvastatin—atherosclerosis	0.00118	0.00639	CcSEcCtD
Albendazole—Rash—Ezetimibe—atherosclerosis	0.00118	0.00639	CcSEcCtD
Albendazole—Dermatitis—Ezetimibe—atherosclerosis	0.00118	0.00639	CcSEcCtD
Albendazole—Headache—Ezetimibe—atherosclerosis	0.00118	0.00635	CcSEcCtD
Albendazole—Vomiting—Simvastatin—atherosclerosis	0.00114	0.00615	CcSEcCtD
Albendazole—Nausea—Lovastatin—atherosclerosis	0.00114	0.00614	CcSEcCtD
Albendazole—Rash—Simvastatin—atherosclerosis	0.00113	0.00609	CcSEcCtD
Albendazole—Dermatitis—Simvastatin—atherosclerosis	0.00113	0.00609	CcSEcCtD
Albendazole—Headache—Simvastatin—atherosclerosis	0.00112	0.00606	CcSEcCtD
Albendazole—Nausea—Ezetimibe—atherosclerosis	0.00112	0.00602	CcSEcCtD
Albendazole—Dizziness—Niacin—atherosclerosis	0.00109	0.00587	CcSEcCtD
Albendazole—Dizziness—Pravastatin—atherosclerosis	0.00107	0.00578	CcSEcCtD
Albendazole—Nausea—Simvastatin—atherosclerosis	0.00106	0.00574	CcSEcCtD
Albendazole—Vomiting—Niacin—atherosclerosis	0.00105	0.00564	CcSEcCtD
Albendazole—Rash—Niacin—atherosclerosis	0.00104	0.0056	CcSEcCtD
Albendazole—Dermatitis—Niacin—atherosclerosis	0.00104	0.00559	CcSEcCtD
Albendazole—Headache—Niacin—atherosclerosis	0.00103	0.00556	CcSEcCtD
Albendazole—Vomiting—Pravastatin—atherosclerosis	0.00103	0.00556	CcSEcCtD
Albendazole—Rash—Pravastatin—atherosclerosis	0.00102	0.00551	CcSEcCtD
Albendazole—Dermatitis—Pravastatin—atherosclerosis	0.00102	0.00551	CcSEcCtD
Albendazole—Headache—Pravastatin—atherosclerosis	0.00101	0.00547	CcSEcCtD
Albendazole—Nausea—Niacin—atherosclerosis	0.000976	0.00527	CcSEcCtD
Albendazole—Nausea—Pravastatin—atherosclerosis	0.000961	0.00519	CcSEcCtD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	7.28e-05	0.000645	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PLTP—atherosclerosis	7.19e-05	0.000637	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	7.02e-05	0.000621	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	7.02e-05	0.000621	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	7.02e-05	0.000621	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	7.02e-05	0.000621	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	6.93e-05	0.000614	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	6.74e-05	0.000597	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	6.69e-05	0.000593	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	6.64e-05	0.000589	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—MAPK3—atherosclerosis	6.64e-05	0.000588	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	6.57e-05	0.000582	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	6.55e-05	0.00058	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	6.48e-05	0.000574	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—CXCL8—atherosclerosis	6.44e-05	0.00057	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	6.42e-05	0.000568	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ABCG8—atherosclerosis	6.23e-05	0.000552	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—LTA4H—atherosclerosis	6.23e-05	0.000552	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	6.18e-05	0.000547	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ABCG1—atherosclerosis	6.17e-05	0.000546	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	6.11e-05	0.000541	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—LDLRAP1—atherosclerosis	6.1e-05	0.000541	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	5.97e-05	0.000528	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—MAPK3—atherosclerosis	5.93e-05	0.000526	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—FABP4—atherosclerosis	5.8e-05	0.000514	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—LCAT—atherosclerosis	5.8e-05	0.000514	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PLTP—atherosclerosis	5.74e-05	0.000508	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—APOA4—atherosclerosis	5.69e-05	0.000504	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP7A1—atherosclerosis	5.59e-05	0.000495	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	5.59e-05	0.000495	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	5.38e-05	0.000477	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	5.33e-05	0.000472	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	5.32e-05	0.000471	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	5.28e-05	0.000468	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	5.25e-05	0.000465	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP27A1—atherosclerosis	5.17e-05	0.000458	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	5.13e-05	0.000454	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	5.09e-05	0.000451	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—LTA4H—atherosclerosis	4.98e-05	0.000441	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ABCG8—atherosclerosis	4.98e-05	0.000441	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	4.96e-05	0.00044	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ABCG1—atherosclerosis	4.93e-05	0.000436	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	4.91e-05	0.000435	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PLA2G2A—atherosclerosis	4.9e-05	0.000434	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALOX5AP—atherosclerosis	4.9e-05	0.000434	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALOX15—atherosclerosis	4.9e-05	0.000434	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—APOA2—atherosclerosis	4.9e-05	0.000434	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	4.85e-05	0.00043	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ABCG5—atherosclerosis	4.84e-05	0.000429	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	4.83e-05	0.000428	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	4.77e-05	0.000422	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	4.71e-05	0.000417	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—LPA—atherosclerosis	4.67e-05	0.000414	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	4.64e-05	0.000411	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—FABP4—atherosclerosis	4.63e-05	0.00041	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—LCAT—atherosclerosis	4.63e-05	0.00041	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	4.58e-05	0.000406	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—APOA4—atherosclerosis	4.55e-05	0.000403	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—BGN—atherosclerosis	4.53e-05	0.000401	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	4.49e-05	0.000398	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—APOA5—atherosclerosis	4.48e-05	0.000397	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP7A1—atherosclerosis	4.47e-05	0.000396	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PLTP—atherosclerosis	4.43e-05	0.000392	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	4.4e-05	0.00039	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	4.35e-05	0.000386	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PLA2G1B—atherosclerosis	4.31e-05	0.000382	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	4.27e-05	0.000378	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	4.23e-05	0.000374	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	4.23e-05	0.000374	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	4.22e-05	0.000374	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALOX5—atherosclerosis	4.17e-05	0.000369	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	4.17e-05	0.000369	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	4.13e-05	0.000366	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP27A1—atherosclerosis	4.13e-05	0.000366	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	4.05e-05	0.000359	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	4.04e-05	0.000358	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ABCG1—atherosclerosis	3.93e-05	0.000348	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALOX15—atherosclerosis	3.91e-05	0.000347	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—APOA2—atherosclerosis	3.91e-05	0.000347	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PLA2G2A—atherosclerosis	3.91e-05	0.000347	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALOX5AP—atherosclerosis	3.91e-05	0.000347	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ABCG5—atherosclerosis	3.87e-05	0.000342	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.85e-05	0.000341	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—LTA4H—atherosclerosis	3.84e-05	0.00034	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCG8—atherosclerosis	3.84e-05	0.00034	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	3.77e-05	0.000334	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NAMPT—atherosclerosis	3.74e-05	0.000331	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—LPA—atherosclerosis	3.73e-05	0.000331	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.72e-05	0.000329	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—LIPC—atherosclerosis	3.71e-05	0.000329	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—LCAT—atherosclerosis	3.7e-05	0.000328	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—FABP4—atherosclerosis	3.7e-05	0.000328	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—APOC3—atherosclerosis	3.69e-05	0.000327	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—LDLR—atherosclerosis	3.67e-05	0.000325	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—APOA4—atherosclerosis	3.63e-05	0.000322	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—BGN—atherosclerosis	3.62e-05	0.00032	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CETP—atherosclerosis	3.58e-05	0.000317	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—APOA5—atherosclerosis	3.58e-05	0.000317	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP7A1—atherosclerosis	3.57e-05	0.000316	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PLA2G1B—atherosclerosis	3.45e-05	0.000305	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SCARB1—atherosclerosis	3.43e-05	0.000304	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.41e-05	0.000302	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	3.4e-05	0.000301	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.34e-05	0.000296	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALOX5—atherosclerosis	3.33e-05	0.000295	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP27A1—atherosclerosis	3.3e-05	0.000292	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	3.24e-05	0.000287	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—HMGCR—atherosclerosis	3.24e-05	0.000287	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.2e-05	0.000284	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	3.17e-05	0.00028	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALOX15—atherosclerosis	3.12e-05	0.000277	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	3.12e-05	0.000277	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—APOA2—atherosclerosis	3.12e-05	0.000277	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	3.12e-05	0.000277	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ABCG5—atherosclerosis	3.09e-05	0.000273	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.08e-05	0.000273	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCG1—atherosclerosis	3.04e-05	0.000269	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NAMPT—atherosclerosis	2.98e-05	0.000264	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—LPA—atherosclerosis	2.98e-05	0.000264	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—LIPC—atherosclerosis	2.97e-05	0.000263	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—APOC3—atherosclerosis	2.95e-05	0.000261	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—LDLR—atherosclerosis	2.93e-05	0.00026	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.92e-05	0.000259	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ABCA1—atherosclerosis	2.89e-05	0.000256	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—BGN—atherosclerosis	2.89e-05	0.000256	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.87e-05	0.000254	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CETP—atherosclerosis	2.86e-05	0.000253	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—APOA5—atherosclerosis	2.86e-05	0.000253	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—FABP4—atherosclerosis	2.85e-05	0.000253	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—LCAT—atherosclerosis	2.85e-05	0.000253	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	2.81e-05	0.000249	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APOA4—atherosclerosis	2.8e-05	0.000248	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.78e-05	0.000246	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP7A1—atherosclerosis	2.75e-05	0.000244	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	2.75e-05	0.000244	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SCARB1—atherosclerosis	2.74e-05	0.000243	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.72e-05	0.000241	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.69e-05	0.000239	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.69e-05	0.000238	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALOX5—atherosclerosis	2.66e-05	0.000235	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HMGCR—atherosclerosis	2.59e-05	0.000229	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP27A1—atherosclerosis	2.54e-05	0.000225	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	2.54e-05	0.000225	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—HMOX1—atherosclerosis	2.48e-05	0.000219	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.45e-05	0.000217	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	2.41e-05	0.000214	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APOA2—atherosclerosis	2.41e-05	0.000214	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	2.41e-05	0.000214	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALOX15—atherosclerosis	2.41e-05	0.000214	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NAMPT—atherosclerosis	2.38e-05	0.000211	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCG5—atherosclerosis	2.38e-05	0.000211	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—APOB—atherosclerosis	2.37e-05	0.00021	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.37e-05	0.00021	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—LIPC—atherosclerosis	2.37e-05	0.00021	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—APOC3—atherosclerosis	2.35e-05	0.000208	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—LDLR—atherosclerosis	2.34e-05	0.000207	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTM1—atherosclerosis	2.31e-05	0.000205	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ABCA1—atherosclerosis	2.31e-05	0.000204	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—LPA—atherosclerosis	2.3e-05	0.000204	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CETP—atherosclerosis	2.28e-05	0.000202	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—LPL—atherosclerosis	2.27e-05	0.000201	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—BGN—atherosclerosis	2.23e-05	0.000197	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GPX1—atherosclerosis	2.21e-05	0.000196	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APOA5—atherosclerosis	2.21e-05	0.000195	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SCARB1—atherosclerosis	2.19e-05	0.000194	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CD36—atherosclerosis	2.15e-05	0.000191	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.13e-05	0.000189	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	2.12e-05	0.000188	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HMGCR—atherosclerosis	2.07e-05	0.000183	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALOX5—atherosclerosis	2.05e-05	0.000182	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—MTHFR—atherosclerosis	2.04e-05	0.000181	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PPARA—atherosclerosis	2e-05	0.000177	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HMOX1—atherosclerosis	1.98e-05	0.000175	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—AGT—atherosclerosis	1.94e-05	0.000172	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—APOE—atherosclerosis	1.9e-05	0.000168	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—APOB—atherosclerosis	1.9e-05	0.000168	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CAV1—atherosclerosis	1.88e-05	0.000167	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—APOA1—atherosclerosis	1.88e-05	0.000166	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.86e-05	0.000165	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTM1—atherosclerosis	1.84e-05	0.000163	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ABCA1—atherosclerosis	1.84e-05	0.000163	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.84e-05	0.000163	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—LIPC—atherosclerosis	1.83e-05	0.000162	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APOC3—atherosclerosis	1.82e-05	0.000161	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—LPL—atherosclerosis	1.81e-05	0.00016	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—LDLR—atherosclerosis	1.81e-05	0.00016	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GPX1—atherosclerosis	1.77e-05	0.000156	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CETP—atherosclerosis	1.76e-05	0.000156	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CD36—atherosclerosis	1.72e-05	0.000152	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CG—atherosclerosis	1.71e-05	0.000152	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.69e-05	0.00015	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PPARG—atherosclerosis	1.65e-05	0.000147	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—MTHFR—atherosclerosis	1.63e-05	0.000144	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—INS—atherosclerosis	1.62e-05	0.000144	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PPARA—atherosclerosis	1.6e-05	0.000142	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.59e-05	0.000141	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HMOX1—atherosclerosis	1.58e-05	0.00014	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—AGT—atherosclerosis	1.55e-05	0.000137	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—APOE—atherosclerosis	1.52e-05	0.000134	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—APOB—atherosclerosis	1.51e-05	0.000134	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CAV1—atherosclerosis	1.5e-05	0.000133	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—APOA1—atherosclerosis	1.5e-05	0.000133	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALB—atherosclerosis	1.49e-05	0.000132	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTM1—atherosclerosis	1.47e-05	0.00013	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—LPL—atherosclerosis	1.44e-05	0.000128	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NOS3—atherosclerosis	1.42e-05	0.000126	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.42e-05	0.000126	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GPX1—atherosclerosis	1.41e-05	0.000125	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CD36—atherosclerosis	1.37e-05	0.000122	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CG—atherosclerosis	1.37e-05	0.000121	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PPARG—atherosclerosis	1.32e-05	0.000117	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTGS2—atherosclerosis	1.3e-05	0.000115	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—MTHFR—atherosclerosis	1.3e-05	0.000115	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—INS—atherosclerosis	1.3e-05	0.000115	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PPARA—atherosclerosis	1.28e-05	0.000113	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—AGT—atherosclerosis	1.24e-05	0.00011	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.22e-05	0.000108	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—APOE—atherosclerosis	1.21e-05	0.000107	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CAV1—atherosclerosis	1.2e-05	0.000106	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—APOA1—atherosclerosis	1.2e-05	0.000106	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALB—atherosclerosis	1.19e-05	0.000105	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APOB—atherosclerosis	1.17e-05	0.000103	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NOS3—atherosclerosis	1.14e-05	0.000101	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.14e-05	0.000101	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—LPL—atherosclerosis	1.12e-05	9.88e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CG—atherosclerosis	1.09e-05	9.68e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GPX1—atherosclerosis	1.09e-05	9.64e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CD36—atherosclerosis	1.06e-05	9.39e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PPARG—atherosclerosis	1.05e-05	9.35e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTGS2—atherosclerosis	1.04e-05	9.21e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—INS—atherosclerosis	1.03e-05	9.17e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—MTHFR—atherosclerosis	1e-05	8.89e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PPARA—atherosclerosis	9.85e-06	8.73e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AGT—atherosclerosis	9.54e-06	8.45e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALB—atherosclerosis	9.49e-06	8.4e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APOE—atherosclerosis	9.35e-06	8.28e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CAV1—atherosclerosis	9.26e-06	8.2e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APOA1—atherosclerosis	9.24e-06	8.19e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NOS3—atherosclerosis	9.07e-06	8.04e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CG—atherosclerosis	8.44e-06	7.47e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTGS2—atherosclerosis	8.3e-06	7.35e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PPARG—atherosclerosis	8.14e-06	7.21e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—INS—atherosclerosis	7.99e-06	7.07e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALB—atherosclerosis	7.32e-06	6.49e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NOS3—atherosclerosis	7e-06	6.2e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—AKT1—atherosclerosis	6.54e-06	5.79e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTGS2—atherosclerosis	6.4e-06	5.67e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—AKT1—atherosclerosis	5.22e-06	4.63e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—AKT1—atherosclerosis	4.17e-06	3.69e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AKT1—atherosclerosis	3.22e-06	2.85e-05	CbGpPWpGaD
